Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT03001492
Other study ID # Progesterone
Secondary ID
Status Recruiting
Phase N/A
First received December 17, 2016
Last updated December 23, 2016
Start date December 2016

Study information

Verified date December 2016
Source Assiut University
Contact Osama Abdalmageed
Email drosamast1981@gmail.com
Is FDA regulated No
Health authority Egypt: Ministry of Higher Education
Study type Observational

Clinical Trial Summary

Elevation of serum progesterone on the day of ovulation triggering in IVF/ICSI cycles is suggested to be associated with compromized outcomes. Others found that this rise didnot affect the IVF/ICSI outcomes. It is still controversal if premature luteinization would affect the IVF/ICSI outcomes.


Recruitment information / eligibility

Status Recruiting
Enrollment 200
Est. completion date
Est. primary completion date June 2018
Accepts healthy volunteers No
Gender Female
Age group 18 Years to 42 Years
Eligibility Inclusion Criteria:

- Planned fresh Embryo transfer

Exclusion Criteria:

- Cancelation of the embryo transfer for any reason

Study Design

Observational Model: Cohort, Time Perspective: Prospective


Related Conditions & MeSH terms


Locations

Country Name City State
Egypt Osama Abdalmageed Assiut Non-US/Non-Canadian

Sponsors (1)

Lead Sponsor Collaborator
Assiut University

Country where clinical trial is conducted

Egypt, 

References & Publications (1)

Sönmezer M, Pelin Cil A, Atabekoglu C, Ozkavukçu S, Ozmen B. Does premature luteinization or early surge of LH impair cycle outcome? Report of two successful outcomes. J Assist Reprod Genet. 2009 Mar;26(2-3):159-63. doi: 10.1007/s10815-009-9299-5. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Clinical pregnacy rate 14 days after the day of embryo transfer (ET) No